{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:52:30Z","timestamp":1753357950855},"reference-count":36,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,3,15]]},"DOI":"10.2169\/internalmedicine.8290-21","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:09:17Z","timestamp":1630706957000},"page":"841-849","source":"Crossref","is-referenced-by-count":2,"title":["Massive Polycystic Liver with a Poor Performance Status Successfully Treated by ABO-incompatible Adult Living-donor Liver Transplantation While Overcoming Complications"],"prefix":"10.2169","volume":"61","author":[{"given":"Satoshi","family":"Takakusagi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kusunoki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kusunoki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kusunoki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Kizawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kusunoki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Marubashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kusunoki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kosone","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kusunoki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Soejima","sequence":"additional","affiliation":[{"name":"Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Bristowe F. Cystic disease of the liver associated with similar disease of the kidneys. Trans Pathol Soc Lond 7: 229-234, 1856."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Karhunen PJ, Tenhu M. Adult polycystic liver and kidney diseases are separate entities. Clin Genet 30: 29-37, 1986.","DOI":"10.1111\/j.1399-0004.1986.tb00565.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bistritz L, Tamboli C, Bigam D, Bain VG. Polycystic liver disease: experience at a teaching hospital. Am J Gastroenterol 100: 2212-2217, 2005.","DOI":"10.1111\/j.1572-0241.2005.50258.x"},{"key":"4","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2174\/1389450116666150427161743","volume":"18","author":"TV Masyuk","year":"2017","unstructured":"4. Masyuk TV, Masyuk AI, LaRusso NF. Therapeutic targets in polycystic liver disease. Current Drug Targets 18: 950-957, 2017.","journal-title":"Current Drug Targets","ISSN":"http:\/\/id.crossref.org\/issn\/1389-4501","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Aussilhou B, Dokmak S, Dondero F, et al. Treatment of polycystic liver disease. Update on the management. J Visc Surg 155: 471-481, 2018.","DOI":"10.1016\/j.jviscsurg.2018.07.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhang JL, Yuan K, Wang MQ, et al. Transarterial embolization for treatment of symptomatic polycystic liver disease: more than 2-year follow-up. Chin Med J (Engl) 130: 1938-1944, 2017.","DOI":"10.4103\/0366-6999.211882"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wang MQ, Duan F, Liu FY, Wang ZJ, Song P. Treatment of symptomatic polycystic liver disease: transcatheter super-selective hepatic arterial embolization using a mixture of NBCA and iodized oil. Abdom Imaging 38: 465-473, 2013.","DOI":"10.1007\/s00261-012-9931-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. van Keimpema L, de Koning DB, Strijk SP, Drenth JP. Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts. Dig Dis Sci 53: 2251-2257, 2008.","DOI":"10.1007\/s10620-007-0121-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Russell RT, Pinson CW. Surgical management of polycystic liver disease. World J Gastroenterol 13: 5052-5059, 2007.","DOI":"10.3748\/wjg.v13.i38.5052"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Geevarghese SK, Powers T, Marsh JW, Pinson CW. Screening for cerebral aneurysm in patients with polycystic liver disease. South Med J 92: 1167-1170, 1999.","DOI":"10.1097\/00007611-199912000-00006"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11: 1033-1037, 1990.","DOI":"10.1002\/hep.1840110619"},{"key":"12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0016-5085(83)90134-8","volume":"84","author":"LE Porter","year":"1983","unstructured":"12. Porter LE, Elm MS, Van Thiel DH, Dugas MC, Eagon PK. Characterization and quantitation of human hepatic estrogen receptor. Gastroenterology 84: 704-712, 1983.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Porter LE, Elm MS, Van Thiel DH, Eagon PK. Hepatic estrogen receptor in human liver disease. Gastroenterology 92: 735-745, 1987.","DOI":"10.1016\/0016-5085(87)90026-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Porter LE, Van Thiel DH, Eagon PK. Estrogens and progestins as tumor inducers. Semin Liver Dis 7: 24-31, 1987.","DOI":"10.1055\/s-2008-1040560"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gevers TJ, Inthout J, Caroli A, et al. Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data. Gastroenterology 145: 357-365, 2013.","DOI":"10.1053\/j.gastro.2013.04.055"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nakaoka R, Das K, Kudo M, Chung H, Innoue T. Percutaneous aspiration and ethanolamine oleate sclerotherapy for sustained resolution of symptomatic polycystic liver disease: an initial experience. Am J Roentgenol 193: 1540-1545, 2009.","DOI":"10.2214\/AJR.08.1681"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Schnelldorfer T, Torres VE, Zakaria S, Rosen CB, Nagorney DM. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 250: 112-118, 2009.","DOI":"10.1097\/SLA.0b013e3181ad83dc"},{"key":"18","unstructured":"18. Japanese Liver Transplantation Society. Liver transplantation in Japan: registry by the Japanese Liver Transplantation Society. Ishoku 53: 109-123, 2017 (in Japanese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Alsager M, Neong SF, Gandhi R, et al. Liver transplantation in adult polycystic liver disease: the Ontario experience. BMC Gastroenterol 21: 115, 2021.","DOI":"10.1186\/s12876-021-01703-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Keimpema L, Nevens F, Adam R, et al. Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transplant Int 24: 1239-1245, 2011.","DOI":"10.1111\/j.1432-2277.2011.01360.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Starzl TE, Reyes J, Tzakis A, Mieles L, Todo S, Gordon R. Liver transplantation for polycystic liver disease. Arch Surg 125: 575-577, 1990.","DOI":"10.1001\/archsurg.1990.01410170021003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Dan AA, Younossi ZM. Quality of life and liver transplantation in patients with polycystic liver disease. Liver Transpl 12: 1184-1185, 2006.","DOI":"10.1002\/lt.20796"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kim H, Park HC, Ryu H, et al. Clinical correlates of mass effect in autosomal dominant polycystic kidney disease. PLoS One 10: e0144526, 2015.","DOI":"10.1371\/journal.pone.0144526"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wallace D, Cowling TE, Walker K, et al. The impact of performance status on length of hospital stay and clinical complications following liver transplantation. Transplantation 105: 2037-2044, 2021.","DOI":"10.1097\/TP.0000000000003484"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Biffl WL, Narayanan V, Gaudiani JL, Mehler PS. The management of pneumothorax in patients with anorexia nervosa: a case report and review of the literature. Patient Saf Surg 4: 1, 2010.","DOI":"10.1186\/1754-9493-4-1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tobin M, Manthous C. Mechanical ventilation. Am J Respir Crit Care Med 196: 3-4, 2017.","DOI":"10.1164\/rccm.1962P3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Soyama A, Eguchi S, Egawa H. Liver transplantation in Japan. Liver Transpl 22: 1401-1407, 2016.","DOI":"10.1002\/lt.24502"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Stegall M. ABO-incompatible liver transplant: is it justifiable? Liver Transpl 9: 31, 2003.","DOI":"10.1053\/jlts.2003.00000"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 9: 22-30, 2003.","DOI":"10.1053\/jlts.2003.50011"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Egawa H, Ohmori K, Haga H, et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl 13: 579-588, 2007.","DOI":"10.1002\/lt.21092"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kim SH, Lee EC, Shim JR, Park SJ. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation. Liver Int 38: 932-939, 2018.","DOI":"10.1111\/liv.13614"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Egawa H, Teramukai S, Haga H, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transpl 14: 102-114, 2014.","DOI":"10.1111\/ajt.12520"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Song GW, Lee SG, Hwang S, et al. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era. J Hepatol 61: 575-582, 2014.","DOI":"10.1016\/j.jhep.2014.04.039"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kim JM, Kwon CH, Joh JW, et al. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. J Hepatol 59: 1215-1222, 2013.","DOI":"10.1016\/j.jhep.2013.07.035"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Soejima Y, Muto J, Matono R, et al. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases. Clin Transplant 27: 227-231, 2013.","DOI":"10.1111\/ctr.12060"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yadav DK, Hua YF, Bai X, et al. ABO-incompatible adult living donor liver transplantation in the era of rituximab: a systematic review and meta-analysis. Gastroenterol Res Pract 2019.","DOI":"10.1155\/2019\/8589402"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/6\/61_8290-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T03:32:35Z","timestamp":1647660755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/6\/61_8290-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8290-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"article-number":"8290-21"}}